Back
Oramed Pharmaceuticals Stock Price Chart
Sponsored
ORMP
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
ORMP
Oramed Pharmaceuticals
Last Price:
$2.38
Seasonality Move:
6.43%
7 Day Trial
ALL ACCESS PASS
$
7
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing selling pressure, which indicates risk of future bearish movement.
Oramed Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.43 | Sell |
20-day SMA: | 2.43 | Sell |
50-day SMA: | 2.38 | Buy |
200-day SMA: | 2.43 | Sell |
8-day EMA: | 2.42 | Sell |
20-day EMA: | 2.42 | Sell |
50-day EMA: | 2.4 | Sell |
200-day EMA: | 2.49 | Sell |
Oramed Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 47.88 | Sell |
Chaikin Money Flow: | -83771 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.31 - 2.49) | Sell |
Bollinger Bands (100): | (2.31 - 2.45) | Sell |
Oramed Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Oramed Pharmaceuticals Stock
Is Oramed Pharmaceuticals Stock a Buy?
-
Oramed Pharmaceuticals share price is 2.38 while ORMP 8-day simple moving average is 2.43, which is a Sell signal.
-
The stock price of ORMP is 2.38 while Oramed Pharmaceuticals 20-day SMA is 2.43, which makes it a Sell.
-
Oramed Pharmaceuticals 50-day simple moving average is 2.38 while ORMP share price is 2.38, making it a Buy technically.
-
ORMP stock price is 2.38 and Oramed Pharmaceuticals 200-day simple moving average is 2.43, creating a Sell signal.
ORMP Technical Analysis vs Fundamental Analysis
Sell
33
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy or a Sell?
-
Oramed Pharmaceuticals stock is rated a SellThe current Oramed Pharmaceuticals [ORMP] share price is $2.38. The Score for ORMP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Oramed Pharmaceuticals Stock Info
Market Cap:
95.9M
Price in USD:
2.38
Share Volume:
100.5K
Oramed Pharmaceuticals 52-Week Range
52-Week High:
3.67
52-Week Low:
2.00
Sell
33
Oramed Pharmaceuticals (ORMP)
is a Sell
Oramed Pharmaceuticals Share Price Forecast
-
What is the Oramed Pharmaceuticals stock price today?The Oramed Pharmaceuticals stock price is 2.38 USD today.
-
Will ORMP stock go up or go down?Oramed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Oramed Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oramed Pharmaceuticals is overvalued.
Is Oramed Pharmaceuticals Stock a Buy?
-
Oramed Pharmaceuticals share price is 2.38 while ORMP 8-day exponential moving average is 2.42, which is a Sell signal.
-
The stock price of ORMP is 2.38 while Oramed Pharmaceuticals 20-day EMA is 2.42, which makes it a Sell.
-
Oramed Pharmaceuticals 50-day exponential moving average is 2.40 while ORMP share price is 2.38, making it a Sell technically.
-
ORMP stock price is 2.38 and Oramed Pharmaceuticals 200-day simple moving average is 2.49, creating a Sell signal.
Fundamental Analysis of Oramed Pharmaceuticals
Is Oramed Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Oramed Pharmaceuticals
Should I short Oramed Pharmaceuticals stock?
-
ORMP Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Oramed Pharmaceuticals is a Buy
-
Oramed Pharmaceuticals Relative Strength Index (RSI) is 47.88, which suggest Oramed Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Oramed Pharmaceuticals is (2.31 - 2.49), which suggest Oramed Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Oramed Pharmaceuticals is (2.31 - 2.45), which suggest Oramed Pharmaceuticals is a Sell
* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.